Asymchem Laboratories (Tianjin) Investor Relations

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, and continuous flow; and chemical process R&D, analytical services, regulatory, pre-clinical R&D support, PPQ readiness, and back integration services. It also engages in technology services comprising flow chemistry, biocatalysis, fermentation, chiral synthesis, hazardous reactions, low temperature, highly potent, non-precious metal catalysis (NPMC), high-pressure chemistry, electrochemistry, and photochemistry. In addition, the company offers drug products, such as pharma solutions, preformulation, solid oral dosage, and injectables; and biotech solutions, drug substance and development, and consultation services. The company was founded in 1998 and is headquartered in Tianjin, China.

Read Less